Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi-institutional retrospective analysis in 52 patients.

Full Abstract

Malignant ascites is a debilitating condition affecting cancer patients in their terminal stage of disease. Recently, laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) was introduced as a new approach. From September 2001 to August 2008, 52 patients were treated with this new modality. No treatment-related mortality was observed. Median survival was 98 days. One patient developed a clinical recurrence. Laparoscopic HIPEC is a safe and effective method for palliating malignant ascites. (c) 2009 Wiley-Liss, Inc.

Author information

Author/s: Valle, M (M); Van der Speeten, K (K); Garofalo, A (A);

Affiliation: Department of Surgical Oncology, Digestive Branch, Regina Elena National Cancer Institute, Rome, Italy.

Journal and publication information

Publication Type: Journal Article; Multicenter Study

Journal: Journal of surgical oncology (J Surg Oncol), published in United States. (Language: eng)

Reference: 2009-Sep; vol 100 (issue 4) : pp 331-4

Dates: Created 2009/08/27; Completed 2009/09/15;

PMID: 19697441, status: MEDLINE (last retrieved date: 9/15/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.